Filed before 2025Filed 21 August 2024
Human Longevity, Inc. has sold $32M so far
Human Longevity, Inc., a biotech company based in San Diego, CA, has sold $32M so far in its equity round, according to a filing dated 21 August 2024.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 21 August 2024
- First filed
- 7 April 2023
- Round
- Equity round (amended filing)
- Amount sold
- $32M
- Offering size
- $32M
- Investors so far
- 18
- Based in
- San Diego, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 82% of the 1,434 tracked raises with an amount filed in 2024, and than 61% of the 138 in biotech.
Human Longevity, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 21 Aug 2024 | Amended filing | $32M | This raise |
More with Panacea Venture Healthcare on the board
- Myrtelle Inc.$15.7M
- Actym Therapeutics, Inc.$14.1M
Other unannounced rounds
- Thoughtform, Inc.$6.6M
- ProvenAir Technologies, Inc.$488K
- Gravitics, Inc.$17M
- SurgiBox Inc.$486K
- Voxel Labs Inc.$10M
- DVx Atomic Co.$18.5M
Seen it announced?
Send the link and the check will look at it.